0.91) with placebo with an ETD relative to placebo of 3.9 percentage points (95% CI 6.1 to 1.8
Data Extraction Three authors (AP, RKQ, and RKQ) independently extracted information, including general details (authors, DOI, title, journal, publication year), study and participant characteristics (study design, location, study duration, sample sizes in the GLP-1 and control groups, type of GLP-1 agonist used), and outcomes related to pulmonary aspiration
Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: a narrative review and discussion of research needs
The role of genetic mutations in gene PIK3CA in Megalencephaly-Capillary malformation syndrome
MetabolismClinical and Experimental